167 related articles for article (PubMed ID: 11000170)
1. Is a mixture of gadolinium and iodinated contrast material safe during MR arthrography?
Brown RR; Clarke DW; Daffner RH
AJR Am J Roentgenol; 2000 Oct; 175(4):1087-90. PubMed ID: 11000170
[TBL] [Abstract][Full Text] [Related]
2. MR arthrography of the shoulder with gadopentetate dimeglumine: influence of concentration, iodinated contrast material, and time on signal intensity.
Kopka L; Funke M; Fischer U; Keating D; Oestmann J; Grabbe E
AJR Am J Roentgenol; 1994 Sep; 163(3):621-3. PubMed ID: 8079856
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance arthrography of the scapulohumeral joint in dogs, using gadopentetate dimeglumine.
van Bree H; Van Ryssen B; Degryse H; Ramon F
Am J Vet Res; 1995 Mar; 56(3):286-8. PubMed ID: 7771693
[TBL] [Abstract][Full Text] [Related]
4. MR arthrography: impact of steroids, local anesthetics, and iodinated contrast material on gadolinium signal intensity in phantoms at 1.5 and 3.0 T.
Ugas MA; Huynh BH; Fox MG; Patrie JT; Gaskin CM
Radiology; 2014 Aug; 272(2):475-83. PubMed ID: 24661248
[TBL] [Abstract][Full Text] [Related]
5. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
Myhr G; Rinck PA; Børseth A
Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
[TBL] [Abstract][Full Text] [Related]
6. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
7. [Technical considerations for injection of a mixture of iodinated contrast material and Artirem for combined CT and MR arthrography].
Detreille R; Sauer B; Zabel JP; Batch T; Zhu X; Blum A
J Radiol; 2007 Jun; 88(6):863-9. PubMed ID: 17652979
[TBL] [Abstract][Full Text] [Related]
8. MR diagnosis of head and neck tumors: comparison of contrast enhancement with triple-dose gadodiamide and standard-dose gadopentetate dimeglumine in the same patients.
Vogl TJ; Mack MG; Juergens M; Stark M; Pegios W; Bergman C; Grevers G; Western A
AJR Am J Roentgenol; 1994 Aug; 163(2):425-32. PubMed ID: 8037044
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of adverse reactions to gadolinium-based contrast material and management of patients at increased risk: a survey of the American Society of Neuroradiology Fellowship Directors.
Murphy KP; Szopinski KT; Cohan RH; Mermillod B; Ellis JH
Acad Radiol; 1999 Nov; 6(11):656-64. PubMed ID: 10894068
[TBL] [Abstract][Full Text] [Related]
10. Effects of iodinated contrast and field strength on gadolinium enhancement: implications for direct MR arthrography.
Montgomery DD; Morrison WB; Schweitzer ME; Weishaupt D; Dougherty L
J Magn Reson Imaging; 2002 Mar; 15(3):334-43. PubMed ID: 11891980
[TBL] [Abstract][Full Text] [Related]
11. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
Campos A; Aznar L; Alamar R; Castelló JV
Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
[No Abstract] [Full Text] [Related]
12. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
Jung HW; Chang KH; Choi DS; Han MH; Han MC
AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
[TBL] [Abstract][Full Text] [Related]
13. Potential contrast agents for MR arthrography: in vitro evaluation and practical observations.
Hajek PC; Sartoris DJ; Neumann CH; Resnick D
AJR Am J Roentgenol; 1987 Jul; 149(1):97-104. PubMed ID: 3495998
[TBL] [Abstract][Full Text] [Related]
14. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
Jensen MC; Brant-Zawadzki M
AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
[TBL] [Abstract][Full Text] [Related]
15. MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.
van Gils AP; van den Berg R; Falke TH; Bloem JL; Prins HJ; Dillon EH; van der Mey AG; Pauwels EK
AJR Am J Roentgenol; 1994 Jan; 162(1):147-53. PubMed ID: 8273654
[TBL] [Abstract][Full Text] [Related]
16. Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
Beltran J; Chandnani V; McGhee RA; Kursunoglu-Brahme S
AJR Am J Roentgenol; 1991 Mar; 156(3):457-66. PubMed ID: 1899738
[TBL] [Abstract][Full Text] [Related]
17. Fatal reaction to gadopentetate dimeglumine.
Jordan RM; Mintz RD
AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
[No Abstract] [Full Text] [Related]
18. Assessment of utilization and pharmacovigilance based on spontaneous adverse event reporting of gadopentetate dimeglumine as a magnetic resonance contrast agent after 45 million administrations and 15 years of clinical use.
Knopp MV; Balzer T; Esser M; Kashanian FK; Paul P; Niendorf HP
Invest Radiol; 2006 Jun; 41(6):491-9. PubMed ID: 16763467
[TBL] [Abstract][Full Text] [Related]
19. Acute adverse reactions to gadopentetate dimeglumine and gadobenate dimeglumine: experience with 32,659 injections.
Abujudeh HH; Kosaraju VK; Kaewlai R
AJR Am J Roentgenol; 2010 Feb; 194(2):430-4. PubMed ID: 20093606
[TBL] [Abstract][Full Text] [Related]
20. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
[No Abstract] [Full Text] [Related]
[Next] [New Search]
